P H Wiernik
Overview
Explore the profile of P H Wiernik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
579
Citations
4935
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganzel C, Wang Y, Roopcharan K, Sun Z, Rowe J, Fernandez H, et al.
Bone Marrow Transplant
. 2024 Jul;
59(9):1337.
PMID: 39025917
No abstract available.
2.
Ganzel C, Wang Y, Roopcharan K, Sun Z, Rowe J, Fernandez H, et al.
Bone Marrow Transplant
. 2024 May;
59(9):1215-1223.
PMID: 38778148
Several studies reported that patients with acute myeloid leukemia (AML) who remain in long-term remission after allogeneic or autologous transplant have a shorter life expectancy, compared to the general population....
3.
Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kroger N, Hari P, et al.
Bone Marrow Transplant
. 2015 Oct;
51(1):58-66.
PMID: 26437062
Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-term outcomes after allogeneic (allo-)...
4.
Bachanova V, Burns L, Wang T, Carreras J, Gale R, Wiernik P, et al.
Bone Marrow Transplant
. 2014 Nov;
50(2):197-203.
PMID: 25402415
Alternative donor transplantation is increasingly used for high-risk lymphoma patients. We analyzed 1593 transplant recipients (2000-2010) and compared transplant outcomes in recipients of 8/8 allele HLA-A, -B, -C and DRB1...
5.
Lechowicz M, Lazarus H, Carreras J, Laport G, Cutler C, Wiernik P, et al.
Bone Marrow Transplant
. 2014 Jul;
49(11):1360-5.
PMID: 25068422
We describe outcomes after allogeneic hematopoietic cell transplantation (HCT) for mycosis fungoides and Sezary syndrome (MF/SS). Outcomes of 129 subjects with MF/SS reported to the Center for the International Blood...
6.
Gale R, Wiernik P, Lazarus H
Leukemia
. 2014 Apr;
28(10):1949-52.
PMID: 24727674
Despite more than 40 years of extensive study, it remains uncertain which individuals, if any, with acute myelogenous leukemia (AML) in first remission should receive a blood cell or bone...
7.
Bachanova V, Marks D, Zhang M, Wang H, de Lima M, Aljurf M, et al.
Leukemia
. 2013 Aug;
28(3):658-65.
PMID: 23989431
The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) is uncertain. We analyzed 197 adults with Ph+ ALL...
8.
Bishop M, Logan B, Gandham S, Bolwell B, Cahn J, Lazarus H, et al.
Bone Marrow Transplant
. 2007 Dec;
41(7):635-42.
PMID: 18084335
For adults with high-risk or recurrent ALL who lack a suitable sibling donor, the decision between autologous (Auto) and unrelated donor (URD) hematopoietic stem cell transplantation (HSCT) is difficult due...
9.
Alexandrescu D, OBoyle K, Feliz A, Fueg A, Wiernik P
Clin Oncol (R Coll Radiol)
. 2005 Aug;
17(5):358-63.
PMID: 16097567
Solid-pseudopapillary tumour of the pancreas is a rare neoplasm of young women, currently categorised in the World Health Organization classification under exocrine pancreatic tumours. Increased awareness of this condition correlated...
10.
Alexandrescu D, Koulova L, Wiernik P
Clin Exp Dermatol
. 2005 Jun;
30(4):391-4.
PMID: 15953079
We report the case of a 54-year-old African-American male with IgG multiple myeloma (MM) with disease resistant to multiple chemotherapy regimens and immunomodulatory treatment with thalidomide. In spite of achieving...